Biocon announces Q3FY23 results EP News Bureau Feb 15, 2023 Biosimilars Up 54 per cent; Research services up 23 per cent; Generics up 18 per cent
USFDA issues CRL for proposed biosimilar Insulin-R: Biocon PTI Jan 11, 2023 The US Food and Drug Administration (USFDA) issues a Complete Response Letter (CRL) to convey to a company that its initial review…
Biocon starts clinical study to evaluate efficacy of Itolizumab PTI Dec 16, 2022 This is a phase-II randomised, double-blind, parallel-group, placebo and active-controlled (adalimumab), two-treatment period…
‘Science 2022 Top Employer List’ recognises two Indian pharma companies EP News Bureau Nov 2, 2022 Biocon and Dr Reddy's have been recognised by 'Science' magazine in the top 10 and top 20 employers list, respectively
Advancements in oral dosage forms EP News Bureau Sep 9, 2022 Dr Rakesh Bhasin, Vice President and Head – R&D (Formulations), started his presentation by introducing 3D printing to the…
Biocon Q4FY22 revenue at Rs 2,476 crores, up 21 per cent IANS May 2, 2022 FY22 revenue at Rs 8,397 crores, up 14 per cent; core EBITDA up 18 per cent at Rs 2,669 crores; PBT (before Exceptional Item) at…
Kiran Mazumdar-Shaw Elected as Fellow of Royal Society of Edinburgh EP News Bureau Mar 23, 2022 Shaw is among the 80 luminaries to be appointed to the RSE’s Fellowship this year
We will have to see the fine print if there is anything for pharma EP News Bureau Feb 1, 2022 Kiran Mazumdar Shaw, Chairperson, Biocon, and Biocon Biologics, shares her reaction to the union budget 2022 released today
Biocon ties up with Tabuk Pharmaceuticals to commercialise speciality medicines in Middle East Press Trust of India Dec 9, 2021 Under the terms of this agreement, Tabuk Pharmaceuticals will hold the marketing authorisation for select speciality products of…
Biocon gets US FDA nod for generic product Press Trust of India Dec 3, 2021 The product is indicated for the prophylaxis of organ rejection in adult patients receiving a kidney transplant and is available…